Floatz logo

FULVESTRANT

Progesterone Receptor Positive

Emory UniversitySmall moleculePhase 3Dormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Progesterone Receptor Positive cohort.

Asset / SponsorPhaseRating
Inno-206
City of Hope Medical Center
Phase 3BB
Letrozole
Emory University
Phase 2BB
TRASTUZUMAB
M.D. Anderson Cancer Center
Phase 3BB
Cyclophosphamide
City of Hope Medical Center
Phase 3BB
(+)-VINCRISTINE
Mayo Clinic
Phase 3BB

View all 32 →

Same molecule, other indications

FULVESTRANT is also rated in:

Hormone Receptor Positive TumorDormant
BB
Indicative ·
70 / 100
View asset →
hormone receptor-positive breast cancerDormant
BB
Indicative ·
70 / 100
View asset →
invasive breast carcinomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →